Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy
Clinical trial NCT00540384 · COMPLETED
Trial details
- NCT number
- NCT00540384
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2002-03-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.